Evidence map›Paper›PMID 36035941›Full record

ArticleFrontiers in cardiovascular medicine2022

Genetics and clinical phenotype of Erdheim-Chester disease: A case report of constrictive pericarditis and a systematic review of the literature.

Lorenzo Bartoli, Francesco Angeli, Andrea Stefanizzi, Michele Fabrizio, Pasquale Paolisso, Luca Bergamaschi, Alessandro Broccoli, Pier Luigi Zinzani, Nazzareno Galiè, Paola Rucci and 2 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Observational
  4. Article
  5. Review
  6. Cardiac Tamponade in Late Pregnancy Caused byJournal of clinical medicine · 2026
    Article
  7. Review
  8. Article
  9. Recurrent Pericarditis in a Middle-Aged Female with MEFV Mutation.Journal of cardiovascular development and disease · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lorenzo BartoliInstitute of Cardiology, Sant'Orsola-Malpighi Hospital, IRCCS, Bologna, Italy.
Francesco AngeliInstitute of Cardiology, Sant'Orsola-Malpighi Hospital, IRCCS, Bologna, Italy.
Andrea StefanizziInstitute of Cardiology, Sant'Orsola-Malpighi Hospital, IRCCS, Bologna, Italy.
Michele FabrizioInstitute of Cardiology, Sant'Orsola-Malpighi Hospital, IRCCS, Bologna, Italy.
Pasquale PaolissoCardiovascular Center Aalst, OLV-Clinic, Aalst, Belgium.
Luca BergamaschiInstitute of Cardiology, Sant'Orsola-Malpighi Hospital, IRCCS, Bologna, Italy.
Alessandro BroccoliDepartment of Experimental, Diagnostic and Specialty Medicine-DIMES, University of Bologna, Bologna, Italy.
Pier Luigi ZinzaniDepartment of Experimental, Diagnostic and Specialty Medicine-DIMES, University of Bologna, Bologna, Italy.
Nazzareno GalièInstitute of Cardiology, Sant'Orsola-Malpighi Hospital, IRCCS, Bologna, Italy.
Paola RucciDivision of Hygiene and Biostatistics, Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Alberto FoàInstitute of Cardiology, Sant'Orsola-Malpighi Hospital, IRCCS, Bologna, Italy.
Carmine PizziInstitute of Cardiology, Sant'Orsola-Malpighi Hospital, IRCCS, Bologna, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Erdheim-Chester disease (ECD) is a rare form of histiocytosis. An increasing number of genetic mutations have been associated with this syndrome, confirming its possible neoplastic origin. Recently, a connection between the BRAF mutational status and a specific phenotype was described; however, no studies have yet evaluated the correlations between other mutations and the clinical features of the disease. Objectives: This study aims to clarify the association between the clinical phenotype and genetic mutations identified in the neoplastic cell lines of ECD. Methods: We describe a case of ECD characterized by pericardial involvement and a KRAS mutation shared with chronic myelomonocytic leukemia. Hence, through a meta-analysis of individual participant data of all genetically and clinically described cases of ECD in the literature, we aimed to elucidate the association between its clinical phenotype and baseline genetic mutations. Results: Of the 760 studies screened, our review included 133 articles published from 2012 to April 2021. We identified 311 ECD patients whose genotype and phenotype were described. We found five main genes (BRAF, KRAS, NRAS, PIK3CA, and MAP2K1) whose mutation was reported at least three times. Mutation of BRAF led to a neurological disease (183 of 273 patients, 67%; Conclusion: This work implies a possible influence of baseline mutation over the natural history of ECD, underscoring the importance of a thorough genetic analysis in all cases with the ultimate goal of identifying a possible targeted therapy for each patient.

Indexed as

case-reportconstrictive pericarditisErdheim-Chester diseasegenotypephenotypeprecision medicine

Identifiers

PMID36035941
PMCPMC9403274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.